Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.19 USD
-0.03 (-2.46%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $1.19 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.19 | 22.22% |
Earnings Summary
For their last quarter, Aclaris Therapeutics (ACRS) reported earnings of -$0.15 per share, beating the Zacks Consensus Estimate of $-0.19 per share. This reflects a positive earnings surprise of 21.05%. Look out for ACRS's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.18 per share, reflecting a year-over-year increase of 54.76%.
Earnings History
Price & Consensus
Zacks News for ACRS
Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
ACRS: What are Zacks experts saying now?
Zacks Private Portfolio Services